Ionis Pharmaceuticals, Inc.
MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside.
Status:
Application
Type:
Utility
Filling date:
4 Oct 2019
Issue date:
3 Mar 2022